These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diminished Vitamin D Receptor Protein Levels in Crohn's Disease Fibroblasts: Effects of Vitamin D. Gisbert-Ferrándiz L; Cosín-Roger J; Hernández C; Macias-Ceja DC; Ortiz-Masiá D; Salvador P; Esplugues JV; Hinojosa J; Navarro F; Calatayud S; Barrachina MD Nutrients; 2020 Apr; 12(4):. PubMed ID: 32244667 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease. Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485 [TBL] [Abstract][Full Text] [Related]
9. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Lawrance IC; Maxwell L; Doe W Inflamm Bowel Dis; 2001 Aug; 7(3):226-36. PubMed ID: 11515849 [TBL] [Abstract][Full Text] [Related]
10. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis. Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190 [TBL] [Abstract][Full Text] [Related]
11. New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4. Weder B; Schefer F; van Haaften WT; Patsenker E; Stickel F; Mueller S; Hutter S; Schuler C; Baebler K; Wang Y; Mamie C; Dijkstra G; de Vallière C; Imenez Silva PH; Wagner CA; Frey-Wagner I; Ruiz PA; Seuwen K; Rogler G; Hausmann M Inflamm Bowel Dis; 2022 Jan; 28(1):109-125. PubMed ID: 34320209 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1. Yu M; Zhu W; Wang J; Chen X; He X; Lin B; Cen L; Zhou T; Lu C; Yu C; Sun J Inflamm Bowel Dis; 2022 Jun; 28(6):923-935. PubMed ID: 35020883 [TBL] [Abstract][Full Text] [Related]
14. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model. Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142 [TBL] [Abstract][Full Text] [Related]
15. Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation. Xie M; Xiong Z; Yin S; Xiong J; Li X; Jin L; Zhang F; Chen H; Lan P; Lian L Dig Dis Sci; 2022 Jun; 67(6):2232-2243. PubMed ID: 34009553 [TBL] [Abstract][Full Text] [Related]
16. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Stallmach A; Schuppan D; Riese HH; Matthes H; Riecken EO Gastroenterology; 1992 Jun; 102(6):1920-9. PubMed ID: 1587410 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis. Wang R; Wang D; Wang H; Wang T; Weng Y; Zhang Y; Luo Y; Lu Y; Wang Y Front Immunol; 2021; 12():670159. PubMed ID: 34456904 [TBL] [Abstract][Full Text] [Related]